In the setting of increasing challenges for the Pharma industry, medical affairs teams have wide opportunities to take the lead to improve their companies’ positions for a quality drug development, while better addressing needs from patient, physicians, regulators and stakeholders.
Tips to make medical affairs on the top could be summarized to the following:
To do so effectively, medical value teams need to be an integral part of cross-functional product development and product management teams. By working with all pharma functions, they can help increase the company’s understanding of unmet medical needs, and attractiveness of treatment pathways, thus valuating clinical trial protocols options, speeding regulatory approvals and increasing launch success rates.
Never before have Pharma companies developed data and scientific insights. But information channels are changing, and many companies have difficulty communicating science effectively with the growing array of stakeholders that influence purchasing decisions.